NEW Our free Dividend Tracker is live — see what your stocks pay you
Add your stocks and see every dividend they pay you — dates, amounts, and reinvested shares.
Start Free »

MDLN | NASDAQ

$35.74 -$0.52 | -1.43%
TREND SIGNAL:Signal available — unlock to view |2026-10-05

Company Overview:

Market Cap: $48.79B
Trailing PE: 41.6x
FWD PE *: 24.1x
Payout Ratio (TTM): —
52-Week Range: $31.49 - $50.88

* Forward PE is based on street estimates.

0.8 Year MDLN Performance Metrics:

Total Return (with DRIP): -12.8% (-15.77% CAGR)
Total Return (no DRIP): -12.8% (-15.77% CAGR)
Share Price: -12.8% (-15.77% CAGR)
Yield on Cost (with DRIP): —
Total Invested: $10,000
Total Value (with DRIP): $8,717
Total Return $ (with DRIP): -$1,283
MDLN Total Return
1M 3M 6M YTD 1Y 3Y 5Y 10Y
MDLN Price Chart
1M 3M 6M YTD 1Y 3Y 5Y 10Y All

Unlock All Reports & Research Dividend Stocks like a BOSS!

Get 3 Months Free with Annual Plan
PRO
$171 ($14.25/mo) $102.60/yr ($8.55/mo)
7-day free trial
  • Unlimited Portfolio Tracker
  • Portfolio - Lots/Sales/Dividends
  • Portfolio Auto-DRIP
  • Buy/Sell Signals Dashboard
  • Stock Fundamentals
  • Compare Stocks Side-by-Side
  • Revenue & EPS Estimates
  • DCF Valuation Modeling
Try it free for 7 days
Combined 55% Lifetime Discount
Most Popular
PREMIUM
$288 ($24/mo) $172.80/yr ($14.40/mo)
7-day free trial
  • Everything in Pro
  • YieldMax PNL Tracker
  • YieldMax NAV Erosion Alerts
  • YM ETFs Trend Signals
  • 9/21 EMA Trend Signals
  • Stocks Dashboard
Try it free for 7 days
Combined 55% Lifetime Discount
ULTRA
$576 ($48/mo) $345.60/yr ($28.80/mo)
7-day free trial
  • Everything in Premium
  • 15min & 1hr Intraday Signals
  • Group & weekly ETF estimates
  • YouTuber Mode
  • Trades summary + CSV export
  • Priority data & support
Try it free for 7 days
Combined 55% Lifetime Discount

MDLN Financials: Earnings, Revenue, Cash Flow, Ebitda, Cash/Debt, Shares Float, etc:

MDLN - Revenue
MDLN Revenue CAGR:1Y: 11.60%2Y: 0.00%5Y: 0.00%10Y: 0.00%
MDLN - Earnings Per Share (EPS)
MDLN EPS CAGR:1Y: -83.33%2Y: 0.00%5Y: 0.00%10Y: 0.00%
MDLN - Net Income
MDLN Net Income CAGR:1Y: -81.98%2Y: 0.00%5Y: 0.00%10Y: 0.00%
MDLN - EBITDA
MDLN EBITDA CAGR:1Y: -21.73%2Y: 0.00%5Y: 0.00%10Y: 0.00%
MDLN - Free Cash Flow
MDLN Free Cash Flow CAGR:1Y: 486.41%2Y: 0.00%5Y: 0.00%10Y: 0.00%
MDLN - Free Cash Flow / Share
MDLN Free Cash Flow / Share CAGR:1Y: 438.59%2Y: 0.00%5Y: 0.00%10Y: 0.00%
MDLN - Operating Income
MDLN Operating Income CAGR:1Y: -37.20%2Y: 0.00%5Y: 0.00%10Y: 0.00%
MDLN - Gross Profit
MDLN Gross Profit CAGR:1Y: 28.11%2Y: 0.00%5Y: 0.00%10Y: 0.00%
MDLN - Shares Outstanding
MDLN Shares Outstanding CAGR:1Y: 9.39%2Y: 0.00%5Y: 0.00%10Y: 0.00%
MDLN - Share Buybacks
MDLN Share Buybacks CAGR:1Y: 0.00%2Y: 0.00%5Y: 0.00%10Y: 0.00%
MDLN - Stock-Based Comp
MDLN Stock-Based Comp CAGR:1Y: 0.00%2Y: 0.00%5Y: 0.00%10Y: 0.00%
MDLN - Expenses
MDLN Expenses CAGR:1Y: -20.71%2Y: 0.00%5Y: 0.00%10Y: 0.00%

Revenue, EPS, Net Income & Ebitda - Estimates VS Actual:

MDLN - REVENUE: Actual + Estimates
MDLN Actual Revenue CAGR:1Y: 11.60%2Y: 0.00%5Y: 0.00%10Y: 0.00%
MDLN - EPS: Actual + Estimates
MDLN Actual EPS CAGR:1Y: -83.33%2Y: 0.00%5Y: 0.00%10Y: 0.00%
MDLN - NET INCOME: Actual + Estimates
MDLN Actual Net Income CAGR:1Y: -81.98%2Y: 0.00%5Y: 0.00%10Y: 0.00%
MDLN - EBITDA: Actual + Estimates
MDLN Actual EBITDA CAGR:1Y: -21.73%2Y: 0.00%5Y: 0.00%10Y: 0.00%

Ratios, Profit Margins & Return on Capital:

MDLN - Net Profit Margin
MDLN Net Profit Margin CAGR:1Y: -83.88%2Y: 0.00%5Y: 0.00%10Y: 0.00%
MDLN - Gross Profit Margin
MDLN Gross Profit Margin CAGR:1Y: 14.77%2Y: 0.00%5Y: 0.00%10Y: 0.00%
MDLN - Price to Earnings
MDLN Price to Earnings CAGR:1Y: 477.17%2Y: 0.00%5Y: 0.00%10Y: 0.00%
MDLN - Price To Sales Ratio
MDLN Price To Sales Ratio CAGR:1Y: -6.15%2Y: 0.00%5Y: 0.00%10Y: 0.00%
MDLN - Return on Capital Employed
MDLN Return on Capital Employed CAGR:1Y: -41.59%2Y: 0.00%5Y: 0.00%10Y: 0.00%
MDLN - Return on Invested Capital
MDLN Return on Invested Capital CAGR:1Y: -62.69%2Y: 0.00%5Y: 0.00%10Y: 0.00%

Compare stocks side-by-side

Projected Future Returns & Dividends for MDLN

Based on past 0.8-year performance, here are MDLN growth metrics:

Share price CAGR of -15.77%
Dividend CAGR of +0%

Using MDLN CAGR metrics, we can estimate that your initial $10000 investment, over the next 10 years, should grow as follows:

MDLN (DRIP)MDLN - No DRIP
Current Price$35.74$35.74
Start Shares279.80279.80
Start Value$10,000$10,000
  
After 10 years:
Final Share Count279.80279.80
Dividends Payment$0.00$0.00
Annual Dividends$0$0
Yield on cost0.00%0.00%
Share Price$21.36$35.74
Total Dividends$0$0
Final Value$5,976$10,000

Estimated Future Value + Dividends - MDLN

NOTE: Above numbers are our estimate based on MDLN's Dividend and Price CAGR over past 0.8 years. These numbers should only be considered as "potential future returns"! DRIP assumes reinvesting dividends; No-DRIP assumes collecting dividends as cash.

We cannot guarantee that your actual returns will meet these estimates.

Get the best Dividend Stock Research Tools:

Get 3 Months Free with Annual Plan
PRO
$171 ($14.25/mo) $102.60/yr ($8.55/mo)
7-day free trial
  • Unlimited Portfolio Tracker
  • Portfolio - Lots/Sales/Dividends
  • Portfolio Auto-DRIP
  • Buy/Sell Signals Dashboard
  • Stock Fundamentals
  • Compare Stocks Side-by-Side
  • Revenue & EPS Estimates
  • DCF Valuation Modeling
Try it free for 7 days
Combined 55% Lifetime Discount
Most Popular
PREMIUM
$288 ($24/mo) $172.80/yr ($14.40/mo)
7-day free trial
  • Everything in Pro
  • YieldMax PNL Tracker
  • YieldMax NAV Erosion Alerts
  • YM ETFs Trend Signals
  • 9/21 EMA Trend Signals
  • Stocks Dashboard
Try it free for 7 days
Combined 55% Lifetime Discount
ULTRA
$576 ($48/mo) $345.60/yr ($28.80/mo)
7-day free trial
  • Everything in Premium
  • 15min & 1hr Intraday Signals
  • Group & weekly ETF estimates
  • YouTuber Mode
  • Trades summary + CSV export
  • Priority data & support
Try it free for 7 days
Combined 55% Lifetime Discount

Company Info

Medline Inc. (MDLN) had its IPO on 2025-12-17, and is traded on NASDAQ stock exchange.

Medline Inc. is a global manufacturer of medical and surgical products, catering to a broad spectrum of healthcare providers. Their clientele includes hospitals, surgical centers, physician practices, post-acute care facilities, and nursing homes, both domestically and worldwide. The company's operations are divided into two primary divisions: the Medline Brand and Supply Chain Solutions. The Medline Brand division focuses on the production and sourcing of its proprietary medical products, categorized into three key areas: Within Frontline Care, Medline provides a wide array of patient-facing medical and surgical items. This encompasses essentials like wound care treatments, examination gloves, skin and incontinence products, sanitation supplies, various textiles, hand sanitizers, durable medical equipment (DME), patient-specific plastic goods, and decolonization and infection control solutions. The Surgical Solutions category delivers comprehensive product lines for operating rooms and perioperative settings. Offerings range from surgical procedure trays, drapes, and gowns to personal protective equipment (PPE), sterile wraps, various surgical instruments, specialized surgeon's gloves, complete procedure kits, and orthopedic implants. Finally, Laboratory and Diagnostics supplies critical solutions for clinical testing and analysis. This includes point-of-care testing devices, analytical instruments, laboratory consumables, advanced diagnostic equipment, vital signs monitoring systems, and products for anatomic pathology and phlebotomy. The Supply Chain Solutions segment is responsible for sourcing and distributing a diverse portfolio of third-party products, including those from well-known national brands. Beyond distribution, this segment offers comprehensive logistics and supply chain optimization services to clients both domestically and internationally. These optimization services encompass strategic consulting, outsourced management of warehousing and technology, specialized "put-away-ready" packaging, third-party logistics (3PL), inventory rationalization strategies, and efficient route planning. Established in 1966, Medline Inc. maintains its headquarters in Northfield, Illinois.

MDLN website: https://www.medline.com


Get Full Access to All Reports with DRIPCalc PRO

Get 3 Months Free with Annual Plan
PRO
$171 ($14.25/mo) $102.60/yr ($8.55/mo)
7-day free trial
  • Unlimited Portfolio Tracker
  • Portfolio - Lots/Sales/Dividends
  • Portfolio Auto-DRIP
  • Buy/Sell Signals Dashboard
  • Stock Fundamentals
  • Compare Stocks Side-by-Side
  • Revenue & EPS Estimates
  • DCF Valuation Modeling
Try it free for 7 days
Combined 55% Lifetime Discount
Most Popular
PREMIUM
$288 ($24/mo) $172.80/yr ($14.40/mo)
7-day free trial
  • Everything in Pro
  • YieldMax PNL Tracker
  • YieldMax NAV Erosion Alerts
  • YM ETFs Trend Signals
  • 9/21 EMA Trend Signals
  • Stocks Dashboard
Try it free for 7 days
Combined 55% Lifetime Discount
ULTRA
$576 ($48/mo) $345.60/yr ($28.80/mo)
7-day free trial
  • Everything in Premium
  • 15min & 1hr Intraday Signals
  • Group & weekly ETF estimates
  • YouTuber Mode
  • Trades summary + CSV export
  • Priority data & support
Try it free for 7 days
Combined 55% Lifetime Discount
Loading signals…

DCF Model — MDLN

Value from:
Pay up to today
—
vs current price $35.74
—
Cash flow & implied price by year

FCF is negative or missing for this company (common for banks) — the model discounts EPS instead.

EPS is negative or missing for this company — Simple mode uses free cash flow per share instead.

Free cash flow today
—
grows for the next years
Then mature
—
every future dollar counted back to today
Pile of today-dollars
—
÷ shares
Implied price path
YearFCFImplied price
Sensitivity — fair value: growth ↓ × target return →